Weinbach E C, Costa J L, Nelson B D, Claggett C E, Hundal T, Bradley D, Morris S J
Biochem Pharmacol. 1986 May 1;35(9):1445-51. doi: 10.1016/0006-2952(86)90108-5.
The effects of impramine and chlorimipramine on energy-linked reactions in mitochondria were characterized. Both compounds exhibited some characteristics of classical uncouplers of oxidative phosphorylation, i.e. they released respiratory control, hindered ATP synthesis, and enhanced ATPase activity of isolated rat liver mitochondria. Unlike classical uncouplers, however, these compounds only weakly stimulated proton uptake in intact mitochondria. They also exhibited unusual effects on energy-linked reactions in beef heart submitochondrial particles (SMP). Both compounds inhibited NADH oxidation in SMP in an "oligomycin-like" manner, and inhibited ATPase activity of SMP and the soluble F1-ATPase. In contrast, the drugs weakly inhibited ATPase activities of bovine adrenal gland chromaffin granules and resealed granule ghosts. The mechanisms responsible for the multiple effects on mitochondrial energy-linked processes are unclear. They may be related to the hydrophobicity of the drugs, as has been shown for other hydrophobic amines.
对丙咪嗪和氯米帕明在线粒体中与能量相关反应的作用进行了表征。这两种化合物均表现出经典氧化磷酸化解偶联剂的一些特征,即它们解除了呼吸控制,阻碍了ATP合成,并增强了分离的大鼠肝线粒体的ATP酶活性。然而,与经典解偶联剂不同的是,这些化合物仅微弱地刺激完整线粒体中的质子摄取。它们还对牛心亚线粒体颗粒(SMP)中与能量相关的反应表现出异常作用。这两种化合物均以“寡霉素样”方式抑制SMP中的NADH氧化,并抑制SMP和可溶性F1-ATP酶的ATP酶活性。相比之下,这些药物对牛肾上腺嗜铬颗粒和重新封闭的颗粒膜的ATP酶活性抑制作用较弱。对线粒体能量相关过程产生多种作用的机制尚不清楚。它们可能与药物的疏水性有关,正如其他疏水胺所显示的那样。